The Advisory Team at Abintus Bio comprises seasoned experts who provide strategic guidance and insights on the development and implementation of in vivo immune cell reprogramming therapies. They leverage their extensive knowledge in immunology and biotechnology to inform product development, navigate regulatory pathways, and optimize clinical outcomes, ensuring the company's innovations align with industry standards and patient needs.
View all